The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Vaccines & Therapeutics Market Outlook 2024
Synopsis
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
Global mRNA Vaccines & Therapeutics main manufactuers include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc. Europe is the largest market of mRNA vaccines and therapeutics, with a share more than 10%. As for the types of products, it can be divided into infectious disease vaccines and cancer vaccines, which account for about 85%, 15% respectively. In terms of applications, it is widely used in infectious disease and caner, taking proportions 85%, 15% respectively.
The global mRNA Vaccines & Therapeutics market was valued at US$ million in 2020 and is expected to reach US$ 228730 million by the end of 2027, growing at a CAGR of 35.7% during 2021-2027.
This report focuses on mRNA Vaccines & Therapeutics volume and value at the global level, regional level and company level. From a global perspective, this report represents overall mRNA Vaccines & Therapeutics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global mRNA Vaccines & Therapeutics Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
Global mRNA Vaccines & Therapeutics main manufactuers include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc. Europe is the largest market of mRNA vaccines and therapeutics, with a share more than 10%. As for the types of products, it can be divided into infectious disease vaccines and cancer vaccines, which account for about 85%, 15% respectively. In terms of applications, it is widely used in infectious disease and caner, taking proportions 85%, 15% respectively.
The global mRNA Vaccines & Therapeutics market was valued at US$ million in 2020 and is expected to reach US$ 228730 million by the end of 2027, growing at a CAGR of 35.7% during 2021-2027.
This report focuses on mRNA Vaccines & Therapeutics volume and value at the global level, regional level and company level. From a global perspective, this report represents overall mRNA Vaccines & Therapeutics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global mRNA Vaccines & Therapeutics Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Index1 mRNA Vaccines & Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 mRNA Vaccines & Therapeutics Segment by Type
1.2.1 Global mRNA Vaccines & Therapeutics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 mRNA Vaccines & Therapeutics Segment by Application
1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application: (2021-2027)
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Global mRNA Vaccines & Therapeutics Market Size Estimates and Forecasts
1.4.1 Global mRNA Vaccines & Therapeutics Revenue 2016-2027
1.4.2 Global mRNA Vaccines & Therapeutics Sales 2016-2027
1.4.3 mRNA Vaccines & Therapeutics Market Size by Region: 2016 Versus 2021 Versus 2027
2 mRNA Vaccines & Therapeutics Market Competition by Manufacturers
2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2016-2021)
2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers mRNA Vaccines & Therapeutics Manufacturing Sites, Area Served, Product Type
2.5 mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
2.5.1 mRNA Vaccines & Therapeutics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest mRNA Vaccines & Therapeutics Players Market Share by Revenue
2.5.3 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region
3.1 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.3.1 North America mRNA Vaccines & Therapeutics Sales by Country
3.3.2 North America mRNA Vaccines & Therapeutics Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.4.1 Europe mRNA Vaccines & Therapeutics Sales by Country
3.4.2 Europe mRNA Vaccines & Therapeutics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific mRNA Vaccines & Therapeutics Market Facts & Figures by Region
3.5.1 Asia Pacific mRNA Vaccines & Therapeutics Sales by Region
3.5.2 Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.6.1 Latin America mRNA Vaccines & Therapeutics Sales by Country
3.6.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa mRNA Vaccines & Therapeutics Market Facts & Figures by Country
3.7.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country
3.7.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global mRNA Vaccines & Therapeutics Historic Market Analysis by Type
4.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021)
4.3 Global mRNA Vaccines & Therapeutics Price by Type (2016-2021)
5 Global mRNA Vaccines & Therapeutics Historic Market Analysis by Application
5.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
5.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2021)
5.3 Global mRNA Vaccines & Therapeutics Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Moderna Therapeutics
6.1.1 Moderna Therapeutics Corporation Information
6.1.2 Moderna Therapeutics Description and Business Overview
6.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.1.5 Moderna Therapeutics Recent Developments/Updates
6.2 CureVac
6.2.1 CureVac Corporation Information
6.2.2 CureVac Description and Business Overview
6.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
6.2.5 CureVac Recent Developments/Updates
6.3 Translate Bio
6.3.1 Translate Bio Corporation Information
6.3.2 Translate Bio Description and Business Overview
6.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
6.3.5 Translate Bio Recent Developments/Updates
6.4 BioNTech
6.4.1 BioNTech Corporation Information
6.4.2 BioNTech Description and Business Overview
6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
6.4.5 BioNTech Recent Developments/Updates
6.5 Sangamo Therapeutics
6.5.1 Sangamo Therapeutics Corporation Information
6.5.2 Sangamo Therapeutics Description and Business Overview
6.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.5.5 Sangamo Therapeutics Recent Developments/Updates
6.6 Argos Therapeutics
6.6.1 Argos Therapeutics Corporation Information
6.6.2 Argos Therapeutics Description and Business Overview
6.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
6.6.5 Argos Therapeutics Recent Developments/Updates
6.7 In-Cell-Art
6.6.1 In-Cell-Art Corporation Information
6.6.2 In-Cell-Art Description and Business Overview
6.6.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
6.7.5 In-Cell-Art Recent Developments/Updates
6.8 eTheRNA
6.8.1 eTheRNA Corporation Information
6.8.2 eTheRNA Description and Business Overview
6.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
6.8.5 eTheRNA Recent Developments/Updates
6.9 Ethris
6.9.1 Ethris Corporation Information
6.9.2 Ethris Description and Business Overview
6.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
6.9.5 Ethris Recent Developments/Updates
6.10 Tiba Biotechnology
6.10.1 Tiba Biotechnology Corporation Information
6.10.2 Tiba Biotechnology Description and Business Overview
6.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
6.10.5 Tiba Biotechnology Recent Developments/Updates
7 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
7.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
7.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 mRNA Vaccines & Therapeutics Distributors List
8.3 mRNA Vaccines & Therapeutics Customers
9 mRNA Vaccines & Therapeutics Market Dynamics
9.1 mRNA Vaccines & Therapeutics Industry Trends
9.2 mRNA Vaccines & Therapeutics Growth Drivers
9.3 mRNA Vaccines & Therapeutics Market Challenges
9.4 mRNA Vaccines & Therapeutics Market Restraints
10 Global Market Forecast
10.1 mRNA Vaccines & Therapeutics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Type (2022-2027)
10.2 mRNA Vaccines & Therapeutics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Application (2022-2027)
10.3 mRNA Vaccines & Therapeutics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of mRNA Vaccines & Therapeutics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global mRNA Vaccines & Therapeutics Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global mRNA Vaccines & Therapeutics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers mRNA Vaccines & Therapeutics Covered in This Study
Table 5. Global mRNA Vaccines & Therapeutics Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2016-2021)
Table 7. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market mRNA Vaccines & Therapeutics Average Price (USD/Doses) of Key Manufacturers (2016-2021)
Table 10. Manufacturers mRNA Vaccines & Therapeutics Manufacturing Sites and Area Served
Table 11. Manufacturers mRNA Vaccines & Therapeutics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccines & Therapeutics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global mRNA Vaccines & Therapeutics Sales by Region (2016-2021) & (M Doses)
Table 16. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021)
Table 17. Global mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)
Table 19. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)
Table 20. North America mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)
Table 22. Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)
Table 23. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)
Table 24. Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific mRNA Vaccines & Therapeutics Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021)
Table 30. Latin America mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)
Table 32. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)
Table 38. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2016-2021)
Table 39. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
Table 40. Global mRNA Vaccines & Therapeutics Revenue (Million US$) by Type (2016-2021)
Table 41. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2016-2021)
Table 42. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Type (2016-2021)
Table 43. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2016-2021)
Table 44. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
Table 45. Global mRNA Vaccines & Therapeutics Revenue (Million US$) by Application (2016-2021)
Table 46. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2016-2021)
Table 47. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Application (2016-2021)
Table 48. Moderna Therapeutics Corporation Information
Table 49. Moderna Therapeutics Description and Business Overview
Table 50. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 51. Moderna Therapeutics mRNA Vaccines & Therapeutics Product
Table 52. Moderna Therapeutics Recent Developments/Updates
Table 53. CureVac Corporation Information
Table 54. CureVac Description and Business Overview
Table 55. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 56. CureVac mRNA Vaccines & Therapeutics Product
Table 57. CureVac Recent Developments/Updates
Table 58. Translate Bio Corporation Information
Table 59. Translate Bio Description and Business Overview
Table 60. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 61. Translate Bio mRNA Vaccines & Therapeutics Product
Table 62. Translate Bio Recent Developments/Updates
Table 63. BioNTech Corporation Information
Table 64. BioNTech Description and Business Overview
Table 65. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 66. BioNTech mRNA Vaccines & Therapeutics Product
Table 67. BioNTech Recent Developments/Updates
Table 68. Sangamo Therapeutics Corporation Information
Table 69. Sangamo Therapeutics Description and Business Overview
Table 70. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 71. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
Table 72. Sangamo Therapeutics Recent Developments/Updates
Table 73. Argos Therapeutics Corporation Information
Table 74. Argos Therapeutics Description and Business Overview
Table 75. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 76. Argos Therapeutics mRNA Vaccines & Therapeutics Product
Table 77. Argos Therapeutics Recent Developments/Updates
Table 78. In-Cell-Art Corporation Information
Table 79. In-Cell-Art Description and Business Overview
Table 80. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 81. In-Cell-Art mRNA Vaccines & Therapeutics Product
Table 82. In-Cell-Art Recent Developments/Updates
Table 83. eTheRNA Corporation Information
Table 84. eTheRNA Description and Business Overview
Table 85. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 86. eTheRNA mRNA Vaccines & Therapeutics Product
Table 87. eTheRNA Recent Developments/Updates
Table 88. Ethris Corporation Information
Table 89. Ethris Description and Business Overview
Table 90. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 91. Ethris mRNA Vaccines & Therapeutics Product
Table 92. Ethris Recent Developments/Updates
Table 93. Tiba Biotechnology Corporation Information
Table 94. Tiba Biotechnology Description and Business Overview
Table 95. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 96. Tiba Biotechnology mRNA Vaccines & Therapeutics Product
Table 97. Tiba Biotechnology Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. mRNA Vaccines & Therapeutics Distributors List
Table 101. mRNA Vaccines & Therapeutics Customers List
Table 102. mRNA Vaccines & Therapeutics Market Trends
Table 103. mRNA Vaccines & Therapeutics Growth Drivers
Table 104. mRNA Vaccines & Therapeutics Market Challenges
Table 105. mRNA Vaccines & Therapeutics Market Restraints
Table 106. Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2022-2027) & (M Doses)
Table 107. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2022-2027)
Table 108. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 109. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 110. Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2022-2027) & (M Doses)
Table 111. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2022-2027)
Table 112. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 113. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Application (2022-2027)
Table 114. Global mRNA Vaccines & Therapeutics Sales Forecast by Region (2022-2027) & (M Doses)
Table 115. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2022-2027)
Table 116. Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 117. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of mRNA Vaccines & Therapeutics
Figure 2. Global mRNA Vaccines & Therapeutics Market Share by Type in 2020 & 2027
Figure 3. Infectious Disease Vaccines Product Picture
Figure 4. Cancer Vaccines Product Picture
Figure 5. Global mRNA Vaccines & Therapeutics Market Share by Application in 2020 & 2027
Figure 6. Infectious Disease
Figure 7. Cancer
Figure 8. Global mRNA Vaccines & Therapeutics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global mRNA Vaccines & Therapeutics Market Size 2016-2027 (US$ Million)
Figure 10. Global mRNA Vaccines & Therapeutics Sales 2016-2027 (M Doses)
Figure 11. Global mRNA Vaccines & Therapeutics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. mRNA Vaccines & Therapeutics Sales Share by Manufacturers in 2020
Figure 13. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest mRNA Vaccines & Therapeutics Players: Market Share by Revenue in 2020
Figure 15. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021)
Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Region in 2020
Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021)
Figure 19. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2020
Figure 20. United States mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Mexico mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Brazil mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Argentina mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Turkey mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Saudi Arabia mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. UAE mRNA Vaccines & Therapeutics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Sales Market Share of mRNA Vaccines & Therapeutics by Type (2016-2021)
Figure 43. Sales Market Share of mRNA Vaccines & Therapeutics by Application (2016-2021)
Figure 44. Sales Market Share of mRNA Vaccines & Therapeutics by Application in 2020
Figure 45. Revenue Share of mRNA Vaccines & Therapeutics by Application (2016-2021)
Figure 46. Revenue Share of mRNA Vaccines & Therapeutics by Application in 2020
Figure 47. Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure 48. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure 49. mRNA Vaccines & Therapeutics Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
